Guest editor: Prof. Xiaoliang Wang (王晓良), Institute of Materia Medica, Beijing, China
Article deadline: 20 May 2014
Publishing date: 25 August 2014
In this special issue of Neurodegenerative Disease Related Drug Research, articles describing the current drug research advances in the field of neurodegenerative disease will be invited for submission. The direction of submissions can be pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmaceutical analysis, etc. Where appropriate, contributions are also encouraged to discuss novel mechanisms or hot targets of neurodegenerative diseases. It is envisioned that with this Special Issue compilation, researchers in the field will be able to learn the current advances and gain hints for their future works on related drug design and development.
Manuscripts should be submitted online at http://www.elsevier.com/locate/apsb by registering and logging in to this website or by email firstname.lastname@example.org. Papers will be published on-line continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page (http://yxxb.imm.ac.cn/yxxb_en/EN/column/column79.shtml). Please visit the the page before submitting a manuscript. Please give an indication of “submit to special issue” when submitting your article.
Brief introduction of APSB:
Acta Pharmaceutica Sinica B (APSB) (ISSN: 2211-3835) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes research articles, reviews and communications in all areas of pharmaceutical sciences. The journal is co-published by Elsevier B.V., in association with the Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Editor-in-Chief, Jian-dong Jiang, is also the director of Institute of Materia Medica. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics and drug metabolism.
APSB is a part of the series Acta Pharmaceutica Sinica(《药学学报》), which was founded in 1953 and is now the most famous pharmaceutical journal in China. It is the only pharmaceutical journal awarded "China's top 100 journals " for 8 years, continuously. The editorial office of Acta Pharmaceutica Sinica publishs the English journal APSB in order to promote outstanding Chinese researchers to international academy and introduce oversea achievements to Chinese researchers.
E-mail: email@example.com; firstname.lastname@example.org
Acta Pharmaceutica Sinica B